octasa tablet (delayed-release)
tillotts pharma ag - mesalazine - tablet (delayed-release) - 1600mg - mesalazine 1600mg
entocort enema tablets dispersible 0.02mg/ml
tillotts pharma gmbh - budesonide - dispersible tablet - budesonide 0.2 mg/ml - antidiarrheals, intestinal antiinflammatory/antiinfective agents
entocort cr capsule 3mg
tillotts pharma gmbh - budesonide - capsule - budesonide 3 milligram(s) - antidiarrheals, intestinal antiinflammatory/antiinfective agents
colpermin hard gastro-resist. caps.
tillotts pharma gmbh - mentha x piperita l., essential oil 187 mg - gastro-resistant capsule, hard - mentha x piperita, essential oil 187 mg - menthae piperitae aetheroleum
entocort 3 mg hard caps. modif.-rel.
tillotts pharma gmbh - budesonide, micronised 3 mg - modified-release capsule, hard - 3 mg - budesonide 3 mg - budesonide
entocort enema 2,3 mg rect. susp. (tabl.)
tillotts pharma gmbh - budesonide, micronised 2,3 mg/ml - tablet for rectal suspension - 2,3 mg - budesonide 2.3 mg - budesonide
asamovon 1600 mg tabl. modif.-rel.
tillotts pharma gmbh - mesalazine 1600 mg - modified-release tablet - 1600 mg - mesalazine 1600 mg - mesalazine
dificlir 200 mg film coated tablet film-coated tablet
tillotts pharma gmbh, germany - fidaxomicin - film-coated tablet - 200 mg
asacol 1600
tradis gat ltd - mesalazine - modified release tablets - mesalazine 1600 mg - mesalazine - asacol 1600 is indicated for:ulcerative colitis-for the treatment of mild to moderate acute disease-for the maintenance of remission
asacol 800
tradis gat ltd - mesalazine - tablets enteric coated - mesalazine 800 mg - mesalazine - " ulcerative colitis:-for the treatment of mild to moderate acute exacerbations. -for the maintenance of remission.crohn's disease:-for the treatment of acute episodes."